4-{[({1-[4-(Trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl}methyl)amino]carbonyl}benzoic acid → 4-(7-Bromo-5-cyano-1,3-benzoxazol-2-yl)-N-({1-[4-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl}methyl)benzamide
Reaction equation
[F:1][C:2]([F:29])([F:28])[C:3]1[CH:8]=[CH:7][N:6]=[C:5]([N:9]2[CH2:14][CH2:13][CH:12]([CH2:15][NH:16][C:17]([C:19]3[CH:27]=[CH:26][C:22]([C:23]([OH:25])=O)=[CH:21][CH:20]=3)=[O:18])[CH2:11][CH2:10]2)[N:4]=1.[Br:30][C:31]1[C:39]2OC(C3C=CC(C([O-])=O)=CC=3)=[N:36][C:35]=2[CH:34]=[C:33]([C:49]#[N:50])[CH:32]=1>>[Br:30][C:31]1[C:39]2[O:25][C:23]([C:22]3[CH:26]=[CH:27][C:19]([C:17]([NH:16][CH2:15][CH:12]4[CH2:13][CH2:14][N:9]([C:5]5[N:4]=[C:3]([C:2]([F:29])([F:1])[F:28])[CH:8]=[CH:7][N:6]=5)[CH2:10][CH2:11]4)=[O:18])=[CH:20][CH:21]=3)=[N:36][C:35]=2[CH:34]=[C:33]([C:49]#[N:50])[CH:32]=1Participants
3
Procedure
The title compound was prepared from 4-{[({1-[4-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl}methyl)amino]carbonyl}benzoic acid (INTERMEDIATE 25) and 3-amino-5-bromo-4-hydroxybenzonitrile (INTERMEDIATE 1, Step B) by a procedure analogous to that described in Example 109. Mass spectrum (ESI) 587.0 (M+3).
Sources & evidence
- ORD record
- ord-3f907214f5ed443ca135735e23f27124
- Source dataset
- uspto-grants-2013_05
- Patent number
- US08445480B2
Reaction notes
Loading…